Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A two-step centrifugal microfluidic platform for semi-automated IGRA detection of tuberculosis based on chemiluminescence.

The Analyst·2026
Same author

Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies.

Viruses·2026
Same author

Molecular basis of host ATP level modulation by actin-dependent secreted bacterial ATPase and its metaeffector.

Nature communications·2026
Same author

Structural basis and immunogenic efficacy of porcine circovirus type 3 virus-like particle.

Nature communications·2026
Same author

Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia.

Signal transduction and targeted therapy·2026
Same author

An All-in-One Microfluidic Platform for POCT-Ready Nucleic Acid Extraction from Heterogeneous Clinical Samples.

Analytical chemistry·2026

相关实验视频

Updated: Jul 3, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.2K

肝炎E疫苗开发和部署的进展和挑战

Xingcheng Huang1,2, Jiaoxi Lu1,2, Mengjun Liao1,2

  • 1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361000, China.

Vaccines
|July 27, 2024
PubMed
概括

肝炎E病毒 (HEV) 感染导致重大疾病和流行病. HEV 239疫苗显示持续有效10年,提供了对这种肝病有前途的预防策略.

关键词:
这是 HEV HEV.临床试验临床试验临床试验临床试验临床试验乙型肝炎E型肝炎是什么?疫情爆发的情况.在进步方面取得了进展.疫苗 疫苗 疫苗 疫苗

更多相关视频

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

相关实验视频

Last Updated: Jul 3, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.2K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 疫苗学 疫苗学 疫苗学
  • 传染性疾病 传染性疾病

背景情况:

  • 肝炎E是导致急性肝炎的主要原因,死亡率高,特别是在孕妇和患有慢性肝病的人群中.
  • 便-口腔传播促进了大规模的肝炎E病毒 (HEV) 流行.
  • 目前还没有批准针对E型肝炎的特定抗病毒治疗方法.

研究的目的:

  • 审查肝炎E疫苗开发的进展和挑战.
  • 为了突出许可HEV 239疫苗的有效性和安全性.

主要方法:

  • 对HEV 239疫苗的临床试验数据的审查.
  • 从III期试验中分析长期疗效和安全性数据.
  • 全球HEV疫苗开发格局的总结.

主要成果:

  • 在全球范围内,HEV 239疫苗 (Hecolin) 是唯一获得许可的肝炎E疫苗.
  • 第三阶段试验证明了HEV 239疫苗的安全性和有效性.
  • 三次HEV 239剂量的有效性在10年后仍然为86.6%.

结论:

  • HEV 239疫苗代表了预防E型肝炎的重大进展.
  • 持续的研究和开发对于解决HEV疫苗接种的剩余挑战至关重要.
  • 有效的疫苗对于控制HEV流行病和保护脆弱人群至关重要.